Pharmaceutical counterfeiting is widely accepted to be a serious, global problem. No longer just a scourge on the developing world, counterfeit drugs now affect industrialised nations including the member states of the European Union. This is an issue that must be faced by businesses worldwide.

Today, it is estimated that up to 10% of all drugs may be counterfeit. But international and national organisations, as well as governmental authorities, appear to be unanimous in their assertion that is it extremely difficult to establish reliable statistics regarding the size of the phenomenon - or even to determine what constitutes counterfeiting. So, as well as discussing the extent of the problem, this report explores the definitions - in itself an indication of the many varied forms counterfeiting can take.

This is a comprehensive guide and explores the problem from numerous angles and highlights the biggest threats facing the industry. It also explains what is being done to tackle the issue and suggests what companies themselves can do. It is essential reading for anyone concerned with the safe provision of medicines.

Use this report to:
- Understand the problem - both the types and the scope of the threat
- Protect your intellectual property rights
- Know where to turn for help with this issue
- Get ideas to how your company can tackle this problem
- Keep up-to-date with the many anti-counterfeiting initiatives and laws
- Tackle the threat posed by the internet
- Ensure your packaging and labelling is compliant and tamper-proof
- Find the best anti-counterfeiting solution